NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,125 filers reported holding NOVARTIS A G in Q2 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,602 | -5.9% | 55 | -6.8% | 0.01% | +25.0% |
| Q2 2023 | $5,954 | +9.7% | 59 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $5,428 | -15.7% | 59 | -16.9% | 0.00% | -20.0% |
| Q4 2022 | $6,441 | +28.8% | 71 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $5,000 | -16.7% | 71 | -5.3% | 0.00% | -20.0% |
| Q2 2022 | $6,000 | -14.3% | 75 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $7,000 | +40.0% | 75 | +25.0% | 0.01% | +66.7% |
| Q4 2021 | $5,000 | +25.0% | 60 | +27.7% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | 0.0% | 47 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 47 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | -20.0% | 47 | -13.0% | 0.00% | -25.0% |
| Q4 2020 | $5,000 | -61.5% | 54 | -63.0% | 0.00% | -66.7% |
| Q3 2020 | $13,000 | 0.0% | 146 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $13,000 | +225.0% | 146 | +147.5% | 0.01% | +180.0% |
| Q1 2020 | $4,000 | -20.0% | 59 | -1.7% | 0.01% | 0.0% |
| Q4 2019 | $5,000 | – | 60 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |